Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bridging Study With GSK239512 In Patients With Mild To Moderate Alzheimer's Disease

This study has been completed.
Information provided by (Responsible Party):
GlaxoSmithKline Identifier:
First received: April 24, 2008
Last updated: October 11, 2016
Last verified: October 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2009
  Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)